Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001214659-25-005118·Clearside Biomedical, Inc.
Schedule 13G ownership disclosure
CLEARSIDE BIOMEDICAL INC
Common Stock, $0.001 par value · CUSIP: 185063104
Event date: 2025-03-31
- Filing-level shares
- 4,003,553.00
- Percent of class
- 5.2%
- Stephen Boyd Wiles
Shares: 4,003,553.00 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-005118
- Form type
- SCHEDULE 13G
- Filer
- Clearside Biomedical, Inc.
- CIK
- CIK 1539029
- Filed
- Apr 01, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership